136 related articles for article (PubMed ID: 32053085)
21. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
[TBL] [Abstract][Full Text] [Related]
22. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
Wu J; Jiang W; Shen Y; Jiang W; Tian R
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
[TBL] [Abstract][Full Text] [Related]
24. Near-infrared light-mediated DOX-UCNPs@mHTiO
Chen Y; Lin H; Tong R; An N; Qu F
Colloids Surf B Biointerfaces; 2017 Jun; 154():429-437. PubMed ID: 28391106
[TBL] [Abstract][Full Text] [Related]
25. A pH and reduction dual-sensitive polymeric nanomicelle for tumor microenvironment triggered cellular uptake and controlled intracellular drug release.
Su Z; Xu Y; Wang Y; Shi W; Han S; Shuai X
Biomater Sci; 2019 Aug; 7(9):3821-3831. PubMed ID: 31268075
[TBL] [Abstract][Full Text] [Related]
26. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics study on the adsorption and release of doxorubicin by chitosan-decorated graphene.
Shen JW; Li J; Dai J; Zhou M; Ren H; Zhang L; Hu Q; Kong Z; Liang L
Carbohydr Polym; 2020 Nov; 248():116809. PubMed ID: 32919542
[TBL] [Abstract][Full Text] [Related]
28. Reduction/temperature/pH multi-stimuli responsive core cross-linked polypeptide hybrid micelles for triggered and intracellular drug release.
Qu J; Wang QY; Chen KL; Luo JB; Zhou QH; Lin J
Colloids Surf B Biointerfaces; 2018 Oct; 170():373-381. PubMed ID: 29940504
[TBL] [Abstract][Full Text] [Related]
29. Codelivery of Hydrophobic and Hydrophilic Drugs by Graphene-Decorated Magnetic Dendrimers.
Pourjavadi A; Asgari S; Hosseini SH; Akhlaghi M
Langmuir; 2018 Dec; 34(50):15304-15318. PubMed ID: 30424605
[TBL] [Abstract][Full Text] [Related]
30. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems.
Pan Q; Lv Y; Williams GR; Tao L; Yang H; Li H; Zhu L
Carbohydr Polym; 2016 Oct; 151():812-820. PubMed ID: 27474628
[TBL] [Abstract][Full Text] [Related]
31. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of chitosan/polyvinylpyrrolidone coated nanoporous γ-Alumina as a pH-sensitive carrier for controlled release of quercetin.
Nematollahi E; Pourmadadi M; Yazdian F; Fatoorehchi H; Rashedi H; Nigjeh MN
Int J Biol Macromol; 2021 Jul; 183():600-613. PubMed ID: 33932424
[TBL] [Abstract][Full Text] [Related]
33. A tumor targeted near-infrared light-controlled nanocomposite to combat with multidrug resistance of cancer.
Wang M; Wu J; Li Y; Li F; Hu X; Wang G; Han M; Ling D; Gao J
J Control Release; 2018 Oct; 288():34-44. PubMed ID: 30171977
[TBL] [Abstract][Full Text] [Related]
34. Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor.
Jinsui Y; Bing S; Muhua L; Yue L; Jianyi L; Meng D; Kuan C; Chaopin Y; Hui Z; Zhiyi C
Curr Pharm Des; 2018; 24(15):1682-1688. PubMed ID: 29766795
[TBL] [Abstract][Full Text] [Related]
35. A pH-sensitive nanocarrier based on BSA-stabilized graphene-chitosan nanocomposite for sustained and prolonged release of anticancer agents.
Gooneh-Farahani S; Naghib SM; Naimi-Jamal MR; Seyfoori A
Sci Rep; 2021 Aug; 11(1):17404. PubMed ID: 34465842
[TBL] [Abstract][Full Text] [Related]
36. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
Yuan X; Peng S; Lin W; Wang J; Zhang L
J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
[TBL] [Abstract][Full Text] [Related]
37. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
[TBL] [Abstract][Full Text] [Related]
38. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
40. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
